CRNX Insider Trading

Insider Ownership Percentage: 5.90%
Insider Buying (Last 12 Months): $3,499,983.30
Insider Selling (Last 12 Months): $6,237,163.40

Crinetics Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Crinetics Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Crinetics Pharmaceuticals Share Price & Price History

Current Price: $18.09
Price Change: Price Decrease of -0.41 (-2.22%)
As of 11/25/2022 05:00 PM ET

This chart shows the closing price history over time for CRNX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Crinetics Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/15/2022Stephen F. BetzInsiderSell3,126$18.72$58,518.7288,094View SEC Filing Icon  
10/17/2022Stephen F. BetzInsiderSell3,126$17.73$55,423.9894,346View SEC Filing Icon  
10/3/2022Stephen F. BetzInsiderSell3,126$19.64$61,394.6497,472View SEC Filing Icon  
9/15/2022Stephen F. BetzInsiderSell4,168$21.01$87,569.68100,598View SEC Filing Icon  
9/7/2022Stephen F. BetzInsiderSell1,042$21.00$21,882.00104,766View SEC Filing Icon  
7/26/2022Jeff E KnightCOOSell1,152$20.70$23,846.404,950View SEC Filing Icon  
7/13/2022Matthew K. FustDirectorSell5,700$20.96$119,472.0012,536View SEC Filing Icon  
5/2/2022Stephen F. BetzInsiderSell3,247$20.10$65,264.70107,598View SEC Filing Icon  
4/18/2022Perceptive Advisors LlcMajor ShareholderBuy157,515$22.22$3,499,983.305,321,032View SEC Filing Icon  
4/18/2022Stephen F. BetzInsiderSell5,664$25.81$146,187.84110,845View SEC Filing Icon  
4/13/2022Richard Scott StruthersCEOSell138,643$26.83$3,719,791.69730,805View SEC Filing Icon  
4/5/2022Richard Scott StruthersCEOSell21,357$25.34$541,186.3857,400View SEC Filing Icon  
4/4/2022Stephen F. BetzInsiderSell9,000$23.97$215,730.00116,509View SEC Filing Icon  
3/31/2022Stephen F. BetzInsiderSell4,164$21.06$87,693.84View SEC Filing Icon  
3/1/2022Stephen F. BetzInsiderSell3,123$19.73$61,616.79View SEC Filing Icon  
2/7/2022Ajay MadanInsiderSell13,411$17.83$239,118.13View SEC Filing Icon  
2/1/2022Stephen F. BetzInsiderSell3,123$18.79$58,681.17View SEC Filing Icon  
1/18/2022Stephen F. BetzInsiderSell4,168$23.29$97,072.72View SEC Filing Icon  
1/3/2022Stephen F. BetzInsiderSell7,168$28.02$200,847.36View SEC Filing Icon  
12/28/2021Stephen F. BetzInsiderSell3,000$27.95$83,850.00View SEC Filing Icon  
12/15/2021Stephen F. BetzInsiderSell5,668$24.14$136,825.52View SEC Filing Icon  
12/1/2021Stephen F. BetzInsiderSell5,668$27.38$155,189.84View SEC Filing Icon  
11/8/2021Stephen F. BetzInsiderSell3,900$28.42$110,838.00View SEC Filing Icon  
11/5/2021Stephen F. BetzInsiderSell12,600$27.95$352,170.00View SEC Filing Icon  
11/1/2021Matthew K. FustDirectorSell8,954$25.50$228,327.00View SEC Filing Icon  
11/1/2021Stephen F. BetzInsiderSell5,668$24.79$140,509.72View SEC Filing Icon  
10/27/2021Stephen F. BetzInsiderSell3,000$24.00$72,000.00View SEC Filing Icon  
10/25/2021Perceptive Advisors LlcMajor ShareholderBuy1,200,000$19.80$23,760,000.00View SEC Filing Icon  
10/21/2021Stephen F. BetzInsiderSell1,042$21.10$21,986.20View SEC Filing Icon  
9/8/2021Matthew K. FustDirectorSell6,046$25.50$154,173.0018,582View SEC Filing Icon  
9/7/2021Richard Scott StruthersCEOSell30,000$25.00$750,000.00View SEC Filing Icon  
7/26/2021Matthew K. FustDirectorSell5,000$19.59$97,950.00View SEC Filing Icon  
7/19/2021Matthew K. FustDirectorSell5,000$19.50$97,500.0017,536View SEC Filing Icon  
7/12/2021Matthew K. FustDirectorSell5,000$20.71$103,550.00View SEC Filing Icon  
4/8/2021Perceptive Advisors LlcMajor ShareholderBuy304,136$16.44$4,999,995.84View SEC Filing Icon  
12/2/2020Richard Scott StruthersCEOBuy1,000$12.60$12,600.004,000View SEC Filing Icon  
7/15/2020Richard Scott StruthersCEOSell17,500$15.30$267,750.00View SEC Filing Icon  
4/17/2020Vivo Capital Viii, LlcMajor ShareholderSell84,598$15.40$1,302,809.20View SEC Filing Icon  
4/15/2020Vivo Capital Viii, LlcMajor ShareholderSell215,810$15.50$3,345,055.00View SEC Filing Icon  
4/7/2020Vivo Capital Viii, LlcMajor ShareholderSell6,115$14.20$86,833.00View SEC Filing Icon  
4/3/2020Vivo Capital Viii, LlcMajor ShareholderSell300,000$13.80$4,140,000.00View SEC Filing Icon  
3/9/2020Vivo Capital Viii, LlcMajor ShareholderSell528$19.50$10,296.00View SEC Filing Icon  
2/10/2020Vivo Capital Viii, LlcMajor ShareholderSell7,555$21.40$161,677.00View SEC Filing Icon  
2/7/2020Vivo Capital Viii, LlcMajor ShareholderSell5,905$22.00$129,910.00View SEC Filing Icon  
2/4/2020Vivo Capital Viii, LlcMajor ShareholderSell13,460$22.80$306,888.00View SEC Filing Icon  
1/31/2020Vivo Capital Viii, LlcMajor ShareholderSell5,400$21.70$117,180.00View SEC Filing Icon  
1/29/2020Vivo Capital Viii, LlcMajor ShareholderSell13,920$22.20$309,024.00View SEC Filing Icon  
12/16/2019Matthew K. FustDirectorSell3,500$22.50$78,750.0016,036View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

94.42% of Crinetics Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CRNX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Crinetics Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/22/2022Teachers Retirement System of The State of Kentucky44,989$0.88M0.0%N/A0.084%Search for SEC Filing on Google Icon
11/21/2022California State Teachers Retirement System53,010$1.04M0.0%-2.4%0.099%Search for SEC Filing on Google Icon
11/16/2022BNP Paribas Arbitrage SNC45,485$0.89M0.0%+277.7%0.085%Search for SEC Filing on Google Icon
11/15/2022State Street Corp1,808,665$35.52M0.0%+2.7%3.365%Search for SEC Filing on Google Icon
11/15/2022Algert Global LLC17,406$0.34M0.0%-13.3%0.032%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP128,500$2.52M0.0%-1.0%0.239%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP23,256$0.46M0.0%-50.2%0.043%Search for SEC Filing on Google Icon
11/15/2022Trexquant Investment LP24,509$0.48M0.0%+74.9%0.046%Search for SEC Filing on Google Icon
11/15/2022UBS Asset Management Americas Inc.26,066$0.51M0.0%+89.6%0.048%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.2,356,647$46.28M0.0%-3.6%4.384%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD61,635$1.21M0.0%+13.3%0.115%Search for SEC Filing on Google Icon
11/15/2022Ensign Peak Advisors Inc92,324$1.81M0.0%+9.1%0.172%Search for SEC Filing on Google Icon
11/15/2022First Light Asset Management LLC1,346,652$26.45M2.7%+8.5%2.505%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp341,482$6.71M0.0%+3.1%0.635%Search for SEC Filing on Google Icon
11/15/2022Bioimpact Capital LLC364,710$7.16M1.7%-0.5%0.679%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.3,752,022$73.69M0.0%-1.0%6.981%Search for SEC Filing on Google Icon
11/14/2022Tudor Investment Corp Et Al26,753$0.53M0.0%N/A0.050%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.1,310,200$25.73M0.1%-1.7%2.437%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC1,925$38K0.0%-77.3%0.004%Search for SEC Filing on Google Icon
11/14/2022Nuveen Asset Management LLC296,591$5.83M0.0%-26.2%0.552%Search for SEC Filing on Google Icon
11/14/2022UBS Oconnor LLC90,460$1.78M0.0%+3.4%0.168%Search for SEC Filing on Google Icon
11/14/2022MetLife Investment Management LLC27,255$0.54M0.0%+7.2%0.051%Search for SEC Filing on Google Icon
11/10/2022Credit Suisse AG31,066$0.61M0.0%+13.2%0.058%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP536,070$10.53M0.0%-3.2%0.997%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 10,189$0.20M0.0%+126.3%0.019%Search for SEC Filing on Google Icon
11/10/2022Bank of Montreal Can147,000$3.12M0.0%N/A0.273%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG8,139$0.16M0.0%-57.6%0.015%Search for SEC Filing on Google Icon
11/8/2022Fisher Asset Management LLC53,356$1.05M0.0%N/A0.099%Search for SEC Filing on Google Icon
11/8/2022Atom Investors LP48,925$0.96M0.3%-16.5%0.091%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund39,148$0.77M0.0%+15.2%0.073%Search for SEC Filing on Google Icon
11/7/2022Jump Financial LLC28,500$0.56M0.0%N/A0.053%Search for SEC Filing on Google Icon
11/3/2022Teacher Retirement System of Texas12,274$0.24M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC50,605$0.99M0.0%+1,152.0%0.094%Search for SEC Filing on Google Icon
11/2/2022Victory Capital Management Inc.99,068$1.95M0.0%-10.2%0.184%Search for SEC Filing on Google Icon
11/1/2022Great West Life Assurance Co. Can1,457$29K0.0%N/A0.003%Search for SEC Filing on Google Icon
10/31/2022Monarch Partners Asset Management LLC130,860$2.57M0.8%N/A0.243%Search for SEC Filing on Google Icon
10/31/2022SG Americas Securities LLC15,326$0.30M0.0%-39.6%0.029%Search for SEC Filing on Google Icon
10/28/2022Silverarc Capital Management LLC149,027$2.93M1.0%+6.8%0.277%Search for SEC Filing on Google Icon
10/24/2022High Net Worth Advisory Group LLC2,000$39K0.0%N/A0.004%Search for SEC Filing on Google Icon
8/19/2022Walleye Capital LLC154,092$2.87M0.1%-16.0%0.287%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.97,453$1.82M0.0%-11.9%0.181%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD54,407$1.02M0.0%+44.8%0.102%Search for SEC Filing on Google Icon
8/16/2022Driehaus Capital Management LLC5,474,459$102.10M1.7%+10.7%10.231%Search for SEC Filing on Google Icon
8/15/2022AQR Capital Management LLC10,138$0.19M0.0%-61.6%0.019%Search for SEC Filing on Google Icon
8/15/2022State Street Corp1,760,845$32.84M0.0%+3.5%3.291%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC8,478$0.16M0.0%+70.4%0.016%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.1,332,800$24.86M0.1%+10.5%2.491%Search for SEC Filing on Google Icon
8/15/2022Opaleye Management Inc.671,300$12.52M5.6%-3.1%1.255%Search for SEC Filing on Google Icon
8/15/2022Bain Capital Life Sciences Investors LLC2,305,558$43M5.0%+13.6%4.309%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC509,330$9.50M0.0%+115.7%0.952%Search for SEC Filing on Google Icon
8/15/2022Natixis Advisors L.P.11,877$0.22M0.0%N/A0.022%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.13,745$0.26M0.0%-8.5%0.026%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC86,400$1.61M0.0%N/A0.161%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.24,630$0.46M0.0%+7.6%0.046%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp484,281$9.03M0.0%+9.9%0.905%Search for SEC Filing on Google Icon
8/12/2022Ensign Peak Advisors Inc84,624$1.58M0.0%+38.8%0.158%Search for SEC Filing on Google Icon
8/12/2022First Light Asset Management LLC1,240,609$23.14M2.7%+112.9%2.319%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG27,436$0.51M0.0%+10.1%0.051%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC44,769$0.84M0.0%-42.7%0.084%Search for SEC Filing on Google Icon
8/12/2022FMR LLC2,987,020$55.71M0.0%-10.5%5.582%Search for SEC Filing on Google Icon
8/12/2022BNP Paribas Arbitrage SA12,042$0.23M0.0%+207.0%0.023%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers73,556$1.37M0.0%+54.2%0.137%Search for SEC Filing on Google Icon
8/11/2022Trexquant Investment LP14,016$0.26M0.0%N/A0.026%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG19,180$0.36M0.0%-72.0%0.036%Search for SEC Filing on Google Icon
8/11/2022Alps Advisors Inc.31,740$0.59M0.0%-35.0%0.059%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.30,889$0.58M0.0%-62.2%0.058%Search for SEC Filing on Google Icon
8/9/2022Swiss National Bank88,000$1.64M0.0%+11.8%0.164%Search for SEC Filing on Google Icon
8/8/2022Walleye Capital LLC154,092$2.87M0.1%-16.0%0.288%Search for SEC Filing on Google Icon
8/5/2022State Board of Administration of Florida Retirement System17,038$0.32M0.0%N/A0.032%Search for SEC Filing on Google Icon
8/1/2022ProShare Advisors LLC10,079$0.19M0.0%-25.7%0.019%Search for SEC Filing on Google Icon
7/29/2022SG Americas Securities LLC25,392$0.47M0.0%N/A0.047%Search for SEC Filing on Google Icon
7/28/2022Arizona State Retirement System10,078$0.19M0.0%N/A0.019%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.15,269$0.28M0.0%N/A0.029%Search for SEC Filing on Google Icon
7/26/2022Dupont Capital Management Corp8,629$0.16M0.0%+36.3%0.016%Search for SEC Filing on Google Icon
7/25/2022Silverarc Capital Management LLC139,539$2.60M0.8%+22.4%0.261%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank7,228$0.16M0.0%-7.2%0.014%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE97,934$2.15M0.0%+43.8%0.183%Search for SEC Filing on Google Icon
5/27/2022Walleye Capital LLC183,543$4.03M0.1%+109.5%0.343%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA3,923$86K0.0%-62.6%0.007%Search for SEC Filing on Google Icon
5/17/2022Walleye Capital LLC183,543$4.03M0.1%+109.5%0.343%Search for SEC Filing on Google Icon
5/17/2022Jane Street Group LLC14,936$0.33M0.0%N/A0.028%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada3,088$68K0.0%-68.6%0.006%Search for SEC Filing on Google Icon
5/17/2022Ensign Peak Advisors Inc60,961$1.34M0.0%+78.2%0.114%Search for SEC Filing on Google Icon
5/17/2022First Manhattan Co.152,200$3.34M0.0%N/A0.284%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System48,377$1.06M0.0%-7.7%0.101%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.110,603$2.43M0.0%+79.8%0.231%Search for SEC Filing on Google Icon
5/16/2022PDT Partners LLC10,031$0.22M0.0%N/A0.021%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP1,029,364$22.60M0.0%-3.8%2.154%Search for SEC Filing on Google Icon
5/16/2022Deep Track Capital LP1,541,715$33.84M2.2%-18.9%3.226%Search for SEC Filing on Google Icon
5/16/2022State Street Corp1,700,679$37.33M0.0%+30.8%3.559%Search for SEC Filing on Google Icon
5/16/2022Frazier Life Sciences Management L.P.1,414,823$31.06M2.6%N/A2.961%Search for SEC Filing on Google Icon
5/16/2022Ghost Tree Capital LLC85,000$1.87M0.4%-28.2%0.178%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.19,343$0.43M0.0%-89.8%0.040%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG68,493$1.50M0.0%+29.7%0.143%Search for SEC Filing on Google Icon
5/16/2022Novo Holdings A S424,897$9.33M0.4%N/A0.794%Search for SEC Filing on Google Icon
5/13/2022Silverarc Capital Management LLC114,004$2.50M1.0%+1.9%0.239%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp440,524$9.67M0.0%-2.2%0.922%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.298,125$6.54M0.0%+2.9%0.624%Search for SEC Filing on Google Icon
5/13/2022Lazard Asset Management LLC18,612$0.41M0.0%N/A0.039%Search for SEC Filing on Google Icon
5/13/2022First Light Asset Management LLC582,767$12.79M1.1%+113.6%1.220%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Crinetics Pharmaceuticals logo
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase I clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Read More on Crinetics Pharmaceuticals

Today's Range

Now: $18.09
Low: $18.08
High: $18.68

50 Day Range

MA: $18.24
Low: $16.82
High: $20.27

52 Week Range

Now: $18.09
Low: $15.91
High: $28.95

Volume

101,792 shs

Average Volume

283,631 shs

Market Capitalization

$972.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

Who are the company insiders with the largest holdings of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals' top insider investors include:
  1. Perceptive Advisors Llc (Major Shareholder)
  2. Richard Scott Struthers (CEO)
  3. Stephen F Betz (Insider)
  4. Matthew K Fust (Director)
  5. Jeff E Knight (COO)
  6. Ajay Madan (Insider)
Learn More about top insider investors at Crinetics Pharmaceuticals.

Who are the major institutional investors of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals' top institutional investors include:
  1. BlackRock Inc. — 6.98%
  2. Vanguard Group Inc. — 4.38%
  3. State Street Corp — 3.36%
  4. First Light Asset Management LLC — 2.51%
  5. Point72 Asset Management L.P. — 2.44%
  6. Dimensional Fund Advisors LP — 1.00%
Learn More about top institutional investors of Crinetics Pharmaceuticals stock.

Which institutional investors are selling Crinetics Pharmaceuticals stock?

During the previous quarter, CRNX stock was sold by these institutional investors:
  1. Nuveen Asset Management LLC
  2. Vanguard Group Inc.
  3. BlackRock Inc.
  4. Two Sigma Investments LP
  5. Point72 Asset Management L.P.
  6. Dimensional Fund Advisors LP
  7. Victory Capital Management Inc.
  8. UBS Group AG
During the last year, company insiders that have sold Crinetics Pharmaceuticals company stock include:
  1. Perceptive Advisors Llc (Major Shareholder)
  2. Richard Scott Struthers (CEO)
  3. Stephen F Betz (Insider)
  4. Matthew K Fust (Director)
  5. Jeff E Knight (COO)
Learn More investors selling Crinetics Pharmaceuticals stock.

Which institutional investors are buying Crinetics Pharmaceuticals stock?

In the last quarter, CRNX stock was bought by institutional investors including:
  1. Bank of Montreal Can
  2. Monarch Partners Asset Management LLC
  3. First Light Asset Management LLC
  4. Fisher Asset Management LLC
  5. State Street Corp
  6. Barclays PLC
  7. Teachers Retirement System of The State of Kentucky
  8. BNP Paribas Arbitrage SNC
During the previous year, these company insiders have bought Crinetics Pharmaceuticals stock:
  1. Perceptive Advisors Llc (Major Shareholder)
  2. Richard Scott Struthers (CEO)
Learn More investors buying Crinetics Pharmaceuticals stock.